Jose Manuel Soto Soto MD
Asthma & COPD, Interstitial Lung Diseases, Interventional Pulmonology, Pulmonary Vascular Medicine
Physician
Join to View Full Profile
Davis Building 7E4500 San Pablo RdJacksonville, FL 32224
Phone+1 904-953-2861
Fax+1 904-953-2082
Dr. Soto Soto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jose Soto Soto is a pulmonologist based in Jacksonville, FL, specializing in a range of subspecialties including asthma and COPD, interstitial lung diseases, interventional pulmonology, and pulmonary vascular medicine. He completed his medical education at the University of Puerto Rico School of Medicine in 2007, followed by residency and fellowship in pulmonary disease and critical care medicine at Mayo Clinic College of Medicine and Science in Jacksonville. Currently employed in pulmonary and critical care at Mayo Clinic, he has experience in chronic obstructive pulmonary disease, pulmonary arterial hypertension, and endobronchial ultrasonography. Dr. Soto Soto has conducted clinical research and has been involved in clinical trials on COPD and pulmonary hypertension. He has published several papers, including one on bedside phonetic evaluation for dysphagia risk, which has been cited 12 times.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Internal Medicine, 2007 - 2010
University of Puerto Rico School of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2008 - 2027
GA State Medical License 2022 - 2023
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Clinical Trials
- A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2018 May 08
- Evaluation of the Safety and Efficacy of TLD in Patients with COPD Start of enrollment: 2019 May 23
Publications & Presentations
PubMed
- 17 citationsInhaled treprostinil in pulmonary hypertension associated with COPD: PERFECT study results.Steven D Nathan, Rahul Argula, Maria G Trivieri, Sameh Aziz, Elizabeth Gay
The European Respiratory Journal. 2024-06-01 - 12 citationsNovel Bedside Phonetic Evaluation to Identify Dysphagia and Aspiration RiskEmir Festic, Jose M. Soto Soto, Lisa A. Pitre, Marilu Leveton, Danielle M. Ramsey
Chest. 2016-03-01 - 1 citationsLabile hypertension: characteristics of a referred cohort.Matthew R. Elliott, Jose M. Soto Soto, William E. Haley, Peter M. Fitzpatrick, Jamie P. Dwyer
Clinical and Experimental Hypertension. 2013-03-29
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
